Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Caignard

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Leukemia|January 13, 2006
Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromesJ-J Kiladjian, E Bourgeois, I Lobe, et al.
Oncogene|June 13, 2000
Altered natural killer cell differentiation in CD34+ progenitors from chronic myeloid leukemia patientsG Carayol, J Giron-Michel, B Azzarone, et al.
Cancer Research|February 1, 1995
In vivo local expansion of clonal T cell subpopulations in renal cell carcinomaC Gaudin, P Y Dietrich, S Robache, et al.
Tissue Antigens|December 11, 2002
Tumor escape from killing: role of killer inhibitory receptors and acquisition of tumor resistance to cell deathS Chouaib, J Thiery, A Gati, et al.
European Journal of Immunology|May 1, 1992
An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reactionC Genevée, A Diu, J Nierat, et al.
Bulletin Du Cancer|October 2, 2001
[Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring]S Chouaib, H Echchakir, E Angevin, et al.
Bone Marrow Transplantation|October 6, 2009
Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patientsG Pittari, G Fregni, L Roguet, et al.
Cancer Research|March 1, 1994
Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neckA Caignard, P Y Dietrich, V Morand, et al.
Blood|October 15, 1994
In vivo T-cell clonal amplification at time of acute graft-versus-host diseaseP Y Dietrich, A Caignard, A Lim, et al.
Gene Therapy|April 1, 1997
Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cellsJ Zhang, C Asselin-Paturel, F Bex, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Leukemia|January 13, 2006
Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromesJ-J Kiladjian, E Bourgeois, I Lobe, et al.
Oncogene|June 13, 2000
Altered natural killer cell differentiation in CD34+ progenitors from chronic myeloid leukemia patientsG Carayol, J Giron-Michel, B Azzarone, et al.
Cancer Research|February 1, 1995
In vivo local expansion of clonal T cell subpopulations in renal cell carcinomaC Gaudin, P Y Dietrich, S Robache, et al.
Tissue Antigens|December 11, 2002
Tumor escape from killing: role of killer inhibitory receptors and acquisition of tumor resistance to cell deathS Chouaib, J Thiery, A Gati, et al.
European Journal of Immunology|May 1, 1992
An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reactionC Genevée, A Diu, J Nierat, et al.
Bulletin Du Cancer|October 2, 2001
[Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring]S Chouaib, H Echchakir, E Angevin, et al.
Bone Marrow Transplantation|October 6, 2009
Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patientsG Pittari, G Fregni, L Roguet, et al.
Cancer Research|March 1, 1994
Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neckA Caignard, P Y Dietrich, V Morand, et al.
Blood|October 15, 1994
In vivo T-cell clonal amplification at time of acute graft-versus-host diseaseP Y Dietrich, A Caignard, A Lim, et al.
Gene Therapy|April 1, 1997
Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cellsJ Zhang, C Asselin-Paturel, F Bex, et al.
Pageof 6